Breast Cancer Liquid Biopsy Trial

Summary

The purpose of this study is to continue to develop a liquid biopsy (minimally invasive blood test) that can be used to confirm if breast cancer has spread throughout the body and if this liquid biopsy test can provide comparable information to a highly invasive tissue biopsy. The knowledge gained in this study could be used in future studies to confirm cancer recurrence using a safe and minimally invasive procedure. The research will consist of looking for tumor cell(s) circulating in the blood stream and if they are present to characterize them so that more information about the disease can be collected. This information may help us to better understand how to fight cancer.

Conditions

• Breast Cancer
• Cancer

Interventions

PROCEDURE

Blood Draw

Blood will be drawn from each patient to check the concordance between liquid and tissue biopsy

Sponsors & Collaborators

• Epic Sciences

  collaborator INDUSTRY

• DHR Health Institute for Research and Development

  collaborator OTHER

• Memorial Healthcare System

  collaborator OTHER

• University of Saskatchewan

  collaborator OTHER

• Florida Cancer Specialist

  collaborator OTHER

• Montefiore Medical Center

  collaborator OTHER

• Ocala Oncology

  collaborator UNKNOWN

• NY Health d/b/a New York Cancer and Blood Specialists

  collaborator OTHER

• Northwest Community Healthcare

  collaborator UNKNOWN

• Anthony Magliocco

  lead INDUSTRY

Principal Investigators

• Anthony Magliocco, MD · CEO and Founder

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-09-28

Primary Completion

2023-06-30

Completion

2023-07-31

Countries

• United States
• Canada

Study Locations